Jiangsu Weihe Biotechnology Co., Ltd. has settled in China Pharmaceutical City

China Pharmaceutical City, located in Taizhou, an important member city of the Yangtze River Delta, has a total planned area of 30 square miles. It is composed of functional areas such as scientific research and development zone, production and manufacturing zone, exhibition and trading zone, health and medical zone, education and teaching zone, and comprehensive supporting zone. It is the first national level medical and pharmaceutical high-tech zone in China, jointly constructed by the Ministry of Science and Technology, the National Health and Family Planning Commission, the State Food and Drug Administration, the State Administration of Traditional Chinese Medicine, and the People's Government of Jiangsu Province.

Jiangsu Weihe Biotechnology Co., Ltd. (referred to as Weihe Bio) is located in the only national level pharmaceutical high-tech industrial park in China - Taizhou National Pharmaceutical High tech Industrial Park (China Pharmaceutical City). Weihe Biotechnology was founded in 2014 by internationally renowned experts in the field of molecular immunology and returning scholars studying in Europe and America in China's only national level pharmaceutical high-tech industrial park - China Pharmaceutical City.

Yaocheng Dongfang Town

The company's main business direction is product development, service, and sales in the fields of molecular immunity and life sciences. The company is currently committed to the development of molecular immune diagnostic reagents, pharmacogenomics, and high-end scientific research products, all of which will fill the gap in the domestic market.

Weihe Biotechnology (9th Floor, Twin Towers 1)

The company has hundreds of square meters of professional molecular biology laboratories, dozens of sets of professional instruments and equipment, and more than 50% of its employees have professional technical talents with master's degrees or above. In the next three to five years, the company's development goal is to strive for the best product quality in the industry, become a reputable enterprise in the industry, and drive the overall progress of the domestic in vitro diagnostic reagent industry.

Previous article： The designated unit for HLA national reference materials - Weihe List is listed!!!!!

Next article： Innovation and Leadership in HLA Genotyping Testing - Weihe Biological HLA-B * 1502 Testing Product